Living the Alzheimer’s Journey

Bobʼs Last Marathon is a podcast devoted to helping families and friends of people with Alzheimerʼs disease create the best life possible for their loved ones and themselves.

Each episode features firsthand stories from family caregivers and advice from professionals about facing familiar everyday challenges—while continuing to celebrate the essence of loved ones who bring light to our lives.

Subscribe on your favorite platform


EXPERT ROUNDTABLE

Anti-Amyloid Therapies: Progress and Promise

4 pm Eastern time, 1 pm Pacific time

Steven E. Arnold, MD, Harvard Medical School
David A. Wolk, MD, Penn Memory Center
Moderator: Felicia Greenfield, MSW, LCSW, Penn Memory Center

Join us for this 75-minute roundtable as panelists share ideas and answer audience questions. The program will be streamed live. Pre-registered attendees will have access to Q&A and participate in polls.


Featured Episode

PLANNING

Progress on Anti-Amyloid Therapies: Roundtable Excerpt 1

Bob's Last Marathon
Bob’s Last Marathon
Progress on Anti-Amyloid Therapies: Roundtable Excerpt 1
Loading
/

Decades of research have helped elucidate the roles of amyloid plaques and tau tangles in Alzheimer’s disease, identify biomarkers of underlying pathology, and guide the development of new therapies. In this first of two excerpts from a recent roundtable, Dr. Steven E. Arnold, Massachusetts General Hospital, and Dr. David A. Wolk, Penn Memory Center, review our current understanding of amyloid and tau pathologies and the clinical trial data that led to the recent approval of Leqembi (lecanemab), the first fully FDA-approved drug for Alzheimer’s disease in over 20 years.

Mar 6, 2024 19 Min 23 Sec TRANSCRIPT